High Outlier
Strength
3.5 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
63020004901
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
7/1/2016
Active Ingredients
BORTEZOMIBApproval Type
New Drug (NDA)
FDA Application
NDA021602On Market Since
5/13/2003
Pharmacological Classes
Proteasome Inhibitor
Proteasome Inhibitors
Related Drugs
Same classification
No related drugs found.